BALTIMORE, May 7, 2018 – Elixirgen Therapeutics, LLC has now incorporated to become Elixirgen Therapeutics, Inc. This change makes the company a better target for investment from strategic partners or venture capital, which will in turn help the company to further its goals in developing and commercializing its therapies.